These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17011883)

  • 1. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
    Giuffre G
    Am J Ophthalmol; 2006 Oct; 142(4):707; author reply 707-8. PubMed ID: 17011883
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Apushkin MA; Fishman GA
    Am J Ophthalmol; 2006 May; 141(5):850-8. PubMed ID: 16546110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Fishman GA; Fiscella RG; Adelman AE
    Retina; 1997; 17(3):222-31. PubMed ID: 9196934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
    Liew G; Moore AT; Webster AR; Michaelides M
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome.
    Lemos Reis RF; Moreira-Gonçalves N; Estrela Silva SE; Brandão EM; Falcão-Reis FM
    Ophthalmologica; 2015; 233(1):43-50. PubMed ID: 25428176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.
    Genead MA; Fishman GA
    Arch Ophthalmol; 2010 Sep; 128(9):1146-50. PubMed ID: 20837798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.
    Fishman GA; Apushkin MA
    Br J Ophthalmol; 2007 Jun; 91(6):743-5. PubMed ID: 17215269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa.
    Chung H; Hwang JU; Kim JG; Yoon YH
    Retina; 2006 Oct; 26(8):922-7. PubMed ID: 17031294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Topical Dorzolamide on Cystoid Macular Edema in Retinitis Pigmentosa.
    Shimokawa S; Fujiwara K; Murakami Y; Funatsu J; Nakatake S; Yoshida N; Sonoda KH; Ikeda Y
    Ophthalmol Retina; 2020 Oct; 4(10):1036-1039. PubMed ID: 32454228
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa.
    Ikeda Y; Yoshida N; Notomi S; Murakami Y; Hisatomi T; Enaida H; Ishibashi T
    Br J Ophthalmol; 2013 Sep; 97(9):1187-91. PubMed ID: 23782868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa.
    Apushkin MA; Fishman GA; Janowicz MJ
    Ophthalmology; 2004 Oct; 111(10):1899-904. PubMed ID: 15465554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical carbonic anhydrase inhibitors in macular edema associated with Alström syndrome.
    Larrañaga-Fragoso P; Pastora N; Bravo-Ljubetic L; Peralta J; Abelairas-Gómez J
    Ophthalmic Genet; 2016 Dec; 37(4):427-429. PubMed ID: 26894450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors.
    Strong SA; Hirji N; Quartilho A; Kalitzeos A; Michaelides M
    Br J Ophthalmol; 2019 Feb; 103(2):233-237. PubMed ID: 29706600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa.
    Apushkin MA; Fishman GA; Grover S; Janowicz MJ
    Retina; 2007 Oct; 27(8):1112-8. PubMed ID: 18040255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEXAMETHASONE IMPLANT VERSUS TOPICAL CARBONIC ANHYDRASE INHIBITORS IN PATIENTS WITH BILATERAL RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA: A Prospective, Paired-Eye Pilot Study.
    Colombo L; Montesano G; Di Domenico A; Colizzi B; Rissotto R; Maltese P; Bertelli M; Autelitano A; Rossetti L
    Retina; 2024 May; 44(5):852-860. PubMed ID: 38166238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.
    Ikeda Y; Hisatomi T; Yoshida N; Notomi S; Murakami Y; Enaida H; Ishibashi T
    Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):809-14. PubMed ID: 22215259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa.
    Kim JE
    Retina; 2006; 26(9):1094-6. PubMed ID: 17151506
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of topical dorzolamide therapy for cystoid macular edema in a patient with MFRP-related nanophthalmos-retinitis pigmentosa-foveoschisis-optic disk drusen syndrome.
    Zacharias LC; Susanna R; Sundin O; Finzi S; Susanna BN; Takahashi WY
    Retin Cases Brief Rep; 2015; 9(1):61-3. PubMed ID: 25383852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child.
    Bušić M; Bjeloš M; Bosnar D; Ramić S; Bušić I
    Doc Ophthalmol; 2016 Feb; 132(1):67-73. PubMed ID: 26803827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Cystoid Macular Edema in Retinitis Pigmentosa.
    Huckfeldt RM; Comander J
    Semin Ophthalmol; 2017; 32(1):43-51. PubMed ID: 27748628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.